dna Communications

United States

dna Communications is a health communications agency where science and humanity meet. In 2025, dna delivered transformative, industry defining work while expanding its impact across biotech, pharma and public health. The agency welcomed nine new clients, launched dnaHelix to support emerging biotech innovators, and deepened long-standing relationships with companies like Boehringer Ingelheim, Pfizer and Novartis.

dna shaped high visibility national campaigns—from Thanksgiving Day commercials to public health initiatives driving kidney disease testing and maternal immunization—reaching hundreds of millions and advancing measurable health outcomes. The team achieved record cultural relevance through award winning creativity, including MM+M Gold and Clio Health wins, and launched breakthrough community activations like Gen X vaccination storytelling and a Pfizer-first Reddit AMA.

The agency also supported six FDA approvals, translating complex science into accessible narratives that earned top-tier media coverage. Under CEO Mike Rosich and General Manager Sara Baker, dna grew 24% in headcount, fostered a culture of creativity and connection, and strengthened its commitment to societal impact through partnerships such as the one with the Partnership to End Addiction.

With a forward-looking model as part of Current Group, dna is poised to continue championing stories that move people, shift culture and accelerate the future of health.